Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Edelman

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Investigational New Drugs|September 18, 1998
Phase I trial of edatrexate plus carboplatin in advanced solid tumors: amelioration of dose-limiting mucositis by ice chip cryotherapyM J Edelman, D R Gandara, E A Perez, et al.
American Journal of Hematology|January 1, 1990
Clinical manifestations of essential thrombocythemia in young adultsF E Millard, C S Hunter, M Anderson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 11, 2017
Statistical controversies in clinical research: futility analyses in oncology-lessons on potential pitfalls from a randomized controlled trialE Lesaffre, M J Edelman, N H Hanna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
RB status as a determinant of response to UCN-01 in non-small cell lung carcinomaP C Mack, D R Gandara, C Bowen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 11, 2014
Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancerK M Kerr, L Bubendorf, M J Edelman, et al.
Cancer|August 10, 1999
Serotonergic blockade in the treatment of the cancer anorexia-cachexia syndromeM J Edelman, D R Gandara, F J Meyers, et al.
Cancer Chemotherapy and Pharmacology|January 4, 2001
Phase I study of docetaxel and topotecan in patients with solid tumorsK H Tkaczuk, W C Zamboni, N S Tait, et al.
Cancer Chemotherapy and Pharmacology|October 27, 1998
High-dose toremifene as a cisplatin modulator in metastatic non-small cell lung cancer: targeted plasma levels are achievable clinicallyP N Lara, D R Gandara, G T Wurz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 17, 2009
A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic non-small-cell lung cancerJ A Treat, R Gonin, M A Socinski, et al.
Clinical and Translational Science|January 22, 2016
Comparative Effects of CT Imaging Measurement on RECIST End Points and Tumor Growth Kinetics ModelingC H Li, R R Bies, Y Wang, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Investigational New Drugs|September 18, 1998
Phase I trial of edatrexate plus carboplatin in advanced solid tumors: amelioration of dose-limiting mucositis by ice chip cryotherapyM J Edelman, D R Gandara, E A Perez, et al.
American Journal of Hematology|January 1, 1990
Clinical manifestations of essential thrombocythemia in young adultsF E Millard, C S Hunter, M Anderson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 11, 2017
Statistical controversies in clinical research: futility analyses in oncology-lessons on potential pitfalls from a randomized controlled trialE Lesaffre, M J Edelman, N H Hanna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
RB status as a determinant of response to UCN-01 in non-small cell lung carcinomaP C Mack, D R Gandara, C Bowen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 11, 2014
Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancerK M Kerr, L Bubendorf, M J Edelman, et al.
Cancer|August 10, 1999
Serotonergic blockade in the treatment of the cancer anorexia-cachexia syndromeM J Edelman, D R Gandara, F J Meyers, et al.
Cancer Chemotherapy and Pharmacology|January 4, 2001
Phase I study of docetaxel and topotecan in patients with solid tumorsK H Tkaczuk, W C Zamboni, N S Tait, et al.
Cancer Chemotherapy and Pharmacology|October 27, 1998
High-dose toremifene as a cisplatin modulator in metastatic non-small cell lung cancer: targeted plasma levels are achievable clinicallyP N Lara, D R Gandara, G T Wurz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 17, 2009
A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic non-small-cell lung cancerJ A Treat, R Gonin, M A Socinski, et al.
Clinical and Translational Science|January 22, 2016
Comparative Effects of CT Imaging Measurement on RECIST End Points and Tumor Growth Kinetics ModelingC H Li, R R Bies, Y Wang, et al.
Pageof 5